158 related articles for article (PubMed ID: 12760802)
21. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
22. [Gastric neuroendocrine tumor].
Díaz-Sánchez CL; Molano Romero RA; Martínez González M; Márquez Rivera ML; Halabe-Cherem J
Rev Gastroenterol Mex; 1998; 63(2):97-100. PubMed ID: 10068736
[TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine gastric carcinoma. A case report and review of current management].
Mondragón-Sánchez A; Mondragón-Sánchez R; Bernal Maldonado R; Baquera-Heredia J; Gómez-Gómez E
Rev Gastroenterol Mex; 2003; 68(2):129-32. PubMed ID: 15127650
[TBL] [Abstract][Full Text] [Related]
24. [Carcinoid tumors and neuroendocrine carcinomas of the stomach. Prognosis and therapeutic management. Study of 6 cases].
Moreaux J; Martin E; Saliou C
Ann Chir; 1997; 51(2):121-9. PubMed ID: 9297867
[TBL] [Abstract][Full Text] [Related]
25. Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties.
Soga J
J Exp Clin Cancer Res; 1998 Mar; 17(1):3-12. PubMed ID: 9646227
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
27. Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise FL; Duvillard P; Foucan L; Hadoux J; Chougnet CN; Leboulleux S; Malka D; Guigay J; Goere D; Debaere T; Caramella C; Schlumberger M; Planchard D; Elias D; Ducreux M; Scoazec JY; Baudin E
Endocr Relat Cancer; 2013 Oct; 20(5):649-57. PubMed ID: 23845449
[TBL] [Abstract][Full Text] [Related]
28. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
29. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
[TBL] [Abstract][Full Text] [Related]
30. [Clinico-pathological study of solid poorly differentiated carcinoma of the stomach].
Maruyama M; Kitamura M; Arai K; Yoshikawa T; Kosaki G; Takizawa T; Koike M
Gan No Rinsho; 1989 Jul; 35(8):905-11. PubMed ID: 2473227
[TBL] [Abstract][Full Text] [Related]
31. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
32. Hepatoid adenocarcinoma of the stomach with extensive neuroendocrine differentiation and a coexisting carcinoid tumour.
Rassidakis GZ; Delladetsima JK; Letsos SP; Polyzos A; Yannopoulos A
Histopathology; 1998 Aug; 33(2):186-8. PubMed ID: 9762555
[No Abstract] [Full Text] [Related]
33. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
[TBL] [Abstract][Full Text] [Related]
34. Gastric neuroendocrine tumors.
Delle Fave G; Capurso G; Annibale B; Panzuto F
Neuroendocrinology; 2004; 80 Suppl 1():16-9. PubMed ID: 15477710
[TBL] [Abstract][Full Text] [Related]
35. Neuroendocrine neoplasms of the larynx: an overview.
Ferlito A; Silver CE; Bradford CR; Rinaldo A
Head Neck; 2009 Dec; 31(12):1634-46. PubMed ID: 19536850
[TBL] [Abstract][Full Text] [Related]
36. Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
Waldum HL; Haugen OA; Brenna E
Cancer Detect Prev; 1994; 18(6):431-6. PubMed ID: 7867015
[TBL] [Abstract][Full Text] [Related]
37. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumors of the ovary--a review.
Kupryjańczyk J
Verh Dtsch Ges Pathol; 1997; 81():253-9. PubMed ID: 9474878
[TBL] [Abstract][Full Text] [Related]
39. Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases.
Soga J
J Exp Clin Cancer Res; 2002 Dec; 21(4):457-68. PubMed ID: 12636090
[TBL] [Abstract][Full Text] [Related]
40. Gastric-and-intestinal mixed endocrine cell phenotypic expression of carcinoid tumors in the rectum.
Hirata Y; Mizoshita T; Mizushima T; Shimura T; Mori Y; Kubota E; Wada T; Ogasawara N; Tanida S; Kataoka H; Sasaki M; Kamiya T; Tsukamoto T; Tatematsu M; Joh T
Oncol Rep; 2009 Jan; 21(1):107-12. PubMed ID: 19082450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
